Insights

Gathering insights about CytoImmune Therapeutics…

Similar companies to CytoImmune Therapeutics

CytoImmune Therapeutics Tech Stack

CytoImmune Therapeutics uses 8 technology products and services including prettyPhoto, jQuery Migrate, Revslider, and more. Explore CytoImmune Therapeutics's tech stack below.

prettyPhoto
Javascript Libraries
jQuery Migrate
Javascript Libraries
Revslider
Miscellaneous
RSS
Miscellaneous
TablePress
Web Platform Extensions
WP Job Openings
Web Platform Extensions
Apache
Web Servers
Slider Revolution
Widgets

Media & News

CytoImmune Therapeutics's Email Address Formats

CytoImmune Therapeutics uses at least 1 format(s):

CytoImmune Therapeutics Email Formats	Example	Percentage
First@cytoimmune.com	John@cytoimmune.com	40%
First.Last@cytoimmune.com	John.Doe@cytoimmune.com	19%
Last@cytoimmune.com	Doe@cytoimmune.com	1%
First@cytoimmune.com	John@cytoimmune.com	40%

Frequently Asked Questions

Where is CytoImmune Therapeutics's headquarters located?

CytoImmune Therapeutics's main headquarters is located at 1218 S 5th Ave Monrovia, California 91016 US. The company has employees across 1 continents, including North America.

What is CytoImmune Therapeutics's official website and social media links?

CytoImmune Therapeutics's official website is cytoimmune.com and has social profiles on LinkedIn.

How much revenue does CytoImmune Therapeutics generate?

As of October 2024, CytoImmune Therapeutics's annual revenue reached $750K.

What is CytoImmune Therapeutics's SIC code NAICS code?

CytoImmune Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CytoImmune Therapeutics have currently?

As of October 2024, CytoImmune Therapeutics has approximately 51 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. E. V.Chief Medical Officer: R. V.Vice President Regulatory Affairs: O. B.. Explore CytoImmune Therapeutics's employee directory with LeadIQ.

What industry does CytoImmune Therapeutics belong to?

CytoImmune Therapeutics operates in the Biotechnology Research industry.

What technology does CytoImmune Therapeutics use?

CytoImmune Therapeutics's tech stack includes prettyPhotojQuery MigrateRevsliderRSSTablePressWP Job OpeningsApacheSlider Revolution.

What is CytoImmune Therapeutics's email format?

CytoImmune Therapeutics's email format typically follows the pattern of . Find more CytoImmune Therapeutics email formats with LeadIQ.

When was CytoImmune Therapeutics founded?

CytoImmune Therapeutics was founded in 2019.

CytoImmune Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.

Our CoalesceNT™ platform harnesses the power of bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to coordinate an immune response with both natural killer (NK) and T cells. This combination of NK- and T-cell therapy expedites time-to-treatment and delivers a dynamic immune response that reflects natural immunity.

Company Overview

Headquarters: 1218 S 5th Ave Monrovia, California 91016 US
Website: cytoimmune.com
SIC Code: 8733 - Noncommercial Research Organizations
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2019
Employees: 51-200

Media & News

Funding & Financials

$10M
CytoImmune Therapeutics's revenue is in the range of $10M

Funding & Financials

$10M
CytoImmune Therapeutics's revenue is in the range of $10M

Company Leadership

J. E. V.
Chief Executive Officer
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
R. V.
Chief Medical Officer
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. B.
Vice President Regulatory Affairs
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

Y. C.
Manufacturing & Operations Lead/ Head Of Manufacturing
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
O. B.
Vice President Regulatory Affairs
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. A.
Head Of Supply Chain Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. T.
Head Of Analytical Operations
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for CytoImmune Therapeutics and Millions of Other Companies
Sign up for full access to CytoImmune Therapeutics information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to CytoImmune Therapeutics

TC BioPharm

Celyad Oncology

CytoImmune Therapeutics

CytoImmune Therapeutics Tech Stack

Media & News

Matica Biotechnology Inc. partnered with Cytoimmune Therapeutics, Inc. on Oct 9th '24.

Hemostemix Inc. partnered with Cytoimmune Therapeutics, Inc. on Aug 1st '24.

Cytoimmune Therapeutics, Inc. promoted Jose Eduardo Vidal to Chief Executive Officer and member of the Board of Directors on Jul 19th '23.

Cytoimmune Therapeutics, Inc. hires Jose Eduardo Vidal as CEO.

Cytoimmune Therapeutics, Inc. hires Graeme Bell as Board of Directors.

Cytoimmune Therapeutics, Inc. hired Yulii Bogatyrenko as chief business officer on Mar 1st '23.

Cytoimmune Therapeutics, Inc. hired Remus Vezan as Chief Medical Officer on Sep 7th '22.

CytoImmune Therapeutics's Email Address Formats

Frequently Asked Questions

Where is CytoImmune Therapeutics's headquarters located?

What is CytoImmune Therapeutics's official website and social media links?

How much revenue does CytoImmune Therapeutics generate?

What is CytoImmune Therapeutics's SIC code NAICS code?

How many employees does CytoImmune Therapeutics have currently?

What industry does CytoImmune Therapeutics belong to?

What technology does CytoImmune Therapeutics use?

What is CytoImmune Therapeutics's email format?

When was CytoImmune Therapeutics founded?

CytoImmune Therapeutics

Company Overview

Media & News

Matica Biotechnology Inc. partnered with Cytoimmune Therapeutics, Inc. on Oct 9th '24.

Hemostemix Inc. partnered with Cytoimmune Therapeutics, Inc. on Aug 1st '24.

Cytoimmune Therapeutics, Inc. promoted Jose Eduardo Vidal to Chief Executive Officer and member of the Board of Directors on Jul 19th '23.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?